Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 97

Results For "STI"

6874 News Found

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Biotech | April 16, 2026

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments


Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation
News | April 16, 2026

Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation

Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms


Coveris invests €1.8m in Poland to boost speed, capacity & packaging innovation
Packaging | April 16, 2026

Coveris invests €1.8m in Poland to boost speed, capacity & packaging innovation

The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.


Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion
Healthcare | April 15, 2026

Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion

At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning


Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery
R&D | April 15, 2026

Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery

The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners


FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application
Drug Approval | April 15, 2026

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck


Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure
Hospitals | April 15, 2026

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform


Vetter ramps up global clinical manufacturing push with major US & Europe expansion
News | April 15, 2026

Vetter ramps up global clinical manufacturing push with major US & Europe expansion

The goal is to better support drug developers as programs move from laboratory research into clinical trials


NantBioRenewables expands US manufacturing footprint in Alabama
Biotech | April 15, 2026

NantBioRenewables expands US manufacturing footprint in Alabama

To boost compostable packaging, resin innovation, and supply chain speed


Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
R&D | April 15, 2026

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations